ORIENTBIO Inc. (002630) - Total Liabilities

Latest as of December 2025: ₩12.64 Billion KRW ≈ $8.57 Million USD

Based on the latest financial reports, ORIENTBIO Inc. (002630) has total liabilities worth ₩12.64 Billion KRW (≈ $8.57 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 002630 net asset momentum to track the company's year-over-year net asset growth rate.

ORIENTBIO Inc. - Total Liabilities Trend (2006–2025)

This chart illustrates how ORIENTBIO Inc.'s total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of ORIENTBIO Inc. to measure how efficiently the company converts operating cash flow to free cash.

ORIENTBIO Inc. Competitors by Total Liabilities

The table below lists competitors of ORIENTBIO Inc. ranked by their total liabilities.

Company Country Total Liabilities
Eaton Vance California MIT
NYSE MKT:CEV
USA $40.48 Million
Cemas Dokum Sanayi AS
IS:CEMAS
Turkey TL884.75 Million
Masisa
SN:MASISA
Chile CL$199.35 Million
Kumkang Kind
KO:014280
Korea ₩689.84 Billion
Bound and Beyond PCL
BK:BEYOND
Thailand ฿6.57 Billion
Lu Hai Holding Corp
TW:2115
Taiwan NT$1.40 Billion
Datagate Bilgisayar Malzemeleri Ticaret AS
IS:DGATE
Turkey TL5.00 Billion
CombinedX AB
ST:CX
Sweden Skr401.00 Million

Liability Composition Analysis (2006–2025)

This chart breaks down ORIENTBIO Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ORIENTBIO Inc. market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 11.45 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ORIENTBIO Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ORIENTBIO Inc. (2006–2025)

The table below shows the annual total liabilities of ORIENTBIO Inc. from 2006 to 2025.

Year Total Liabilities Change
2025-03-31 ₩12.94 Billion
≈ $8.77 Million
+8.77%
2024-03-31 ₩11.89 Billion
≈ $8.06 Million
+23.13%
2023-03-31 ₩9.66 Billion
≈ $6.54 Million
-55.63%
2022-03-31 ₩21.76 Billion
≈ $14.75 Million
-5.26%
2021-03-31 ₩22.97 Billion
≈ $15.57 Million
+14.05%
2020-03-31 ₩20.14 Billion
≈ $13.65 Million
-6.06%
2019-03-31 ₩21.44 Billion
≈ $14.53 Million
-80.53%
2018-03-31 ₩110.11 Billion
≈ $74.62 Million
+47.44%
2017-03-31 ₩74.68 Billion
≈ $50.61 Million
-11.47%
2016-03-31 ₩84.35 Billion
≈ $57.16 Million
+3.61%
2015-03-31 ₩81.42 Billion
≈ $55.17 Million
+4.67%
2014-03-31 ₩77.78 Billion
≈ $52.71 Million
+5.18%
2013-03-31 ₩73.95 Billion
≈ $50.12 Million
+17.33%
2012-03-31 ₩63.03 Billion
≈ $42.72 Million
+225.32%
2011-03-31 ₩19.38 Billion
≈ $13.13 Million
-54.46%
2010-03-31 ₩42.55 Billion
≈ $28.83 Million
+4.85%
2009-03-31 ₩40.58 Billion
≈ $27.50 Million
-9.68%
2008-03-31 ₩44.93 Billion
≈ $30.45 Million
+60.37%
2007-03-31 ₩28.02 Billion
≈ $18.99 Million
+16.95%
2006-03-31 ₩23.96 Billion
≈ $16.24 Million
--

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology
Market Cap
$71.52 Million
₩105.54 Billion KRW
Market Cap Rank
#20427 Global
#1082 in Korea
Share Price
₩890.00
Change (1 day)
+4.71%
52-Week Range
₩467.00 - ₩1060.00
All Time High
₩6770.89
About

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformati… Read more